True or False: Investigator meetings are mandatory for any multi-center study with six or more sites?

In clinical research, the necessity of investigator meetings can depend on various factors, including the nature of the study, the requirements of the sponsor, and the level of coordination required among sites. It is not universally mandated that every multi-center study with six or more sites must hold an investigator meeting. Instead, these meetings are often considered best practices to facilitate communication, ensure protocol adherence, and foster collaboration among investigators.

While some sponsors may choose to require these meetings to align all sites on study expectations and protocol requirements, it is not a blanket rule applicable to all studies with multiple sites. Therefore, stating that the assertion is false aligns with the understanding that investigator meetings are not mandatory but can be beneficial depending on the specific needs of the study and sponsor preferences.